Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson
Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Journal:
Current Genomics
Volume:
3
Page:
245-263
Author(s):
S. Ortega, M. Malumbres and M. Barbacid
Understanding Mouse Skin Carcinogenesis through Transgenic Approaches
Journal:
Current Genomics
Volume:
3
Page:
335-353
Author(s):
Fernando Larcher, Angel Ramirez, M. Llanos Casanova, Manuel Navarro, Jesus M. Paramio, Paloma Perez, Angustias Page, Mirentxu Santos and Jose L. Jorcano
Viral-Mediated Gene Transfer for Cancer Treatment
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
151-164
Author(s):
Deborah R. Wilson
Adenoviral Vectors for Cancer Gene Therapy
Journal:
Current Genomics
Volume:
3
Page:
163-180
Author(s):
Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
403-417
Author(s):
E.S. White, R.M. Strieter and D.A. Arenberg
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
1-17
Author(s):
sheila A. Stewart and William C. Hahn
Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
77-86
Author(s):
D. L. Crowe